Deborah Waterhouse is leaving ViiV Healthcare to become CEO and managing director of CSL.
Related to this article
AI does not end uncertainty in pharma strategy. Its value depends on how well leaders blend it with experience and evidence while keeping judgment human.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Alcon Acquires Neurotech and Encelto, Ai Proteins Enters Research Collaboration and License Agreement with Astellas Pharma
2
Building Biopharma Manufacturing for Speed, Scale, and Flexibility
3
Pharmaceutical Executive Daily: FDA Approves Hibsago
4
Every AI Agent Will Eventually Fail: Why Healthcare Leaders Need Supervision, Not Hope
5